Vision Medical

Vision Medicals is a leading Chinese biotechnology company specializing in the precision diagnosis of infectious diseases through advanced genomic technologies. Founded in 2018 and headquartered in Guangzhou, the company has developed a comprehensive platform integrating metagenomic next-generation sequencing (mNGS), CRISPR-based point-of-care testing, and AI-driven diagnostic systems. Its flagship products, including PathoSeq and PathoX, enable the unbiased detection of thousands of pathogens from clinical samples such as blood, cerebrospinal fluid, and bronchoalveolar lavage fluid. Vision Medicals gained significant prominence for its critical role in the early identification and monitoring of the SARS-CoV-2 virus and continues to expand its diagnostic capabilities across respiratory, central nervous system, and systemic infections.